Lixivaptan may be effective in reducing water retention associated with heart failure

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1538, 2006-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential role for lixivaptan in heart failure and in hyponatremia

By Zmily Hammam D Khan Nazia S Daifallah Suleiman Ghali Jalal K

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 831-848

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of lixivaptan in euvolemic and hypervolemic hyponatremia and heart failure treatment

By Zmily Hammam D Alani Anas Ghali Jalal K

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 5, 2013-05 ,pp. : 645-655

Informa Healthcare

Access to resources Recommend Favorite

CHARM: Candesartan effective in heart failure

Inpharma, Vol. 1, Iss. 1406, 2003-01 ,pp. : 11-13

Adis International

Access to resources Recommend Favorite

Non-cardiac drugs may be associated with the development or worsening of heart failure or other cardiac consequences

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 8, 2007-08 ,pp. : 18-22

Adis International

Access to resources Recommend Favorite

Enoxaparin may offer benefits for chronic heart failure

Inpharma, Vol. 1, Iss. 1558, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite